Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Potent healing protein becomes target for researchers

By R&D Editors | May 1, 2012

Lactoferrin
is an important iron-binding protein with many health benefits. The
major form of this powerful protein, is secreted into human biofluids
(e.g. milk, blood, tears, saliva), and is responsible for most of the
host-defense properties. Because of the many beneficial activities
associated with it, researchers are starting to use lactoferrin as a
potential therapeutic protein. And, in contrast to many other
therapeutic proteins, which need to be injected into patients,
lactoferrin can be orally active. Lactoferrin is the subject of the
upcoming June issue of the journal Biochemistry and Cell Biology.

“We
now know that lactoferrin is a protein that has many functions in
innate immunity and that it plays a role in protecting us from
bacterial, viral, fungal, and protozoal infections. It can even protect
us from some forms of cancer,” says special issue guest editor Dr. Hans
Vogel, a professor at the University of Calgary. “Some people describe
this protein as the ‘Swiss army knife’ of the human host defense system.
In part it does all this by binding iron, but many other properties of
the protein contribute to its function.”

This
special issue comprises 27 articles and review papers contributed by
leading international researchers. The role of lactoferrin on skin wound
healing; impacts of lactoferrin on small intestinal growth and
development during early life; and use of bovine lactoferrin on the
inhibition of influenza and in the prevention of preterm delivery
associated with sterile inflammation are among the studies presented.

One
important contribution, already published online, is from a Chinese
research group led by Professor Ning Li in Beijing. It shows that
consumption of milk containing increased levels of the lactoferrin
protein modulates the composition of the gut microflora, which in turn
promotes health. This research relies on extensive biochemistry and
molecular biology to produce the protein and to analyze the changes in
the composition of the gut flora. While the article describes an animal
model study, the results can probably be extended to humans. The
research article titled Transgenic milk containing recombinant human
lactoferrin modulates the intestinal flora in piglets is now available
open access on the NRC Research Press website.

Introduction to the special issue by Dr. Hans Vogel

Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets

Source: Canadian Science Publishing (NRC Research Press)

Related Articles Read More >

Pancreas or pancreatic cancer with organs and tumors or cancerous cells 3D rendering illustration with male body. Anatomy, oncology, disease, medical, biology, science, healthcare concepts.
AI tool used to detect pancreatic cancer in routine CT scans in China 
Drones help diagnose deadly whale viruses 
Drowning in variants? Mount Sinai tool adds phenotype filter
Oral Wegovy approval charts a new course for blockbuster drug development
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE